Published in Mol Vis on January 29, 2010
Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy. Mol Vis (2011) 1.09
Roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy. Int J Ophthalmol (2014) 0.87
Homocysteinethiolactone and paraoxonase: novel markers of diabetic retinopathy. Diabetes Care (2010) 0.82
Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients. Mol Vis (2015) 0.79
Immortalized adult rodent Schwann cells as in vitro models to study diabetic neuropathy. Exp Diabetes Res (2011) 0.78
The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells. Int J Mol Med (2015) 0.76
Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy. Mol Vis (2015) 0.75
Vascular adhesion protein 1 in the eye. J Ophthalmol (2013) 0.75
Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone). Oxid Med Cell Longev (2017) 0.75
Oxidative stress in myopia. Oxid Med Cell Longev (2015) 0.75
The Effect of Vitamin E on Oxidative Stress Indicated by Serum Malondialdehyde in Insulin-dependent Type 2 Diabetes Mellitus Patients with Retinopathy. Open Ophthalmol J (2017) 0.75
Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (1989) 8.10
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (1994) 5.19
Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes (2008) 4.13
Retracted Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res (2002) 2.56
Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem (2001) 1.95
Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. J Mol Cell Cardiol (2008) 1.84
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes (1999) 1.76
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest (1996) 1.76
Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes Cells (2008) 1.72
Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord (2008) 1.66
Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta (2003) 1.29
Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients. Mol Vis (2009) 1.18
Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun (1996) 1.13
Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem (1999) 1.13
Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol (1997) 1.12
Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med (2009) 1.08
Lipid peroxidation in proliferative vitreoretinopathies. Eye (Lond) (1999) 1.06
Redox regulation in the extracellular environment. Circ J (2008) 1.02
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med (1992) 0.95
Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study. FEBS Lett (2005) 0.89
Lipid peroxidation in diabetic retinopathy. Ann Univ Mariae Curie Sklodowska Med (2004) 0.88
Elevation of serum thioredoxin levels in patients with type 2 diabetes. Horm Metab Res (2002) 0.88
Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ophthalmic Res (2003) 0.87
Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin. Invest Ophthalmol Vis Sci (2003) 0.86
The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J Atheroscler Thromb (2002) 0.85
The role of the polyol pathway in diabetes mellitus. Br J Hosp Med (1991) 0.81
Restored antioxidant capacity parallels the immunologic and virologic improvement in children with perinatal human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Immunol (2001) 0.78
Accumulation of Nepsilon-(Hexanoyl)lysine, an oxidative stress biomarker, in rice seeds during storage. Biosci Biotechnol Biochem (2005) 0.77
Neuroprotection by Brazilian Green Propolis against In vitro and In vivo Ischemic Neuronal Damage. Evid Based Complement Alternat Med (2005) 1.59
BBF2H7, a novel transmembrane bZIP transcription factor, is a new type of endoplasmic reticulum stress transducer. Mol Cell Biol (2006) 1.52
Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. J Control Release (2009) 1.49
Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab (2006) 1.48
ATP: a vasoactive signal in the pericyte-containing microvasculature of the rat retina. J Physiol (2003) 1.41
Essential roles of heparin-binding epidermal growth factor-like growth factor in the brain. CNS Neurosci Ther (2012) 1.39
Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res (2004) 1.35
Involvement of ER stress in retinal cell death. Mol Vis (2007) 1.32
The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther (2008) 1.32
The first report on intermediate-term outcome of Ex-PRESS glaucoma filtration device implanted under scleral flap in Japanese patients. Clin Ophthalmol (2011) 1.32
Endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses with rapid on-site cytological evaluation by endosonographers without attendance of cytopathologists. J Gastroenterol (2009) 1.29
Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn J Ophthalmol (2005) 1.26
Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions. Life Sci (2006) 1.21
Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons. Brain Res (2007) 1.19
Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients. Mol Vis (2009) 1.18
Agarwood induced laxative effects via acetylcholine receptors on loperamide-induced constipation in mice. Biosci Biotechnol Biochem (2010) 1.17
Brazilian green propolis protects against retinal damage in vitro and in vivo. Evid Based Complement Alternat Med (2006) 1.14
Effect of an inducer of BiP, a molecular chaperone, on endoplasmic reticulum (ER) stress-induced retinal cell death. Invest Ophthalmol Vis Sci (2008) 1.11
Association between meibomian gland changes and aging, sex, or tear function. Cornea (2006) 1.10
On-off system for PI3-kinase-Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN). Proc Natl Acad Sci U S A (2011) 1.10
New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents. Biol Pharm Bull (2003) 1.09
Pancreatic lipoma diagnosed using EUS-FNA. A case report. JOP (2009) 1.08
Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.07
The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. J Neuroinflammation (2013) 1.07
Comparison of bee products based on assays of antioxidant capacities. BMC Complement Altern Med (2009) 1.07
The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis. Sci Rep (2012) 1.06
Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection. Biochem Biophys Res Commun (2009) 1.06
Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy. Am J Ophthalmol (2006) 1.05
Comparison of CCD-equipped laser speckle flowgraphy with hydrogen gas clearance method in the measurement of optic nerve head microcirculation in rabbits. Exp Eye Res (2012) 1.05
Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo. J Pharm Pharmacol (2008) 1.04
CCR7 mediates the migration of Foxp3+ regulatory T cells to the paracortical areas of peripheral lymph nodes through high endothelial venules. J Leukoc Biol (2007) 1.04
Laxative effects of agarwood on low-fiber diet-induced constipation in rats. BMC Complement Altern Med (2010) 1.04
Prostanoids in the therapy of glaucoma. Cardiovasc Drug Rev (2006) 1.03
1,1-diphenyl-2-picrylhydrazyl radical scavenging activity of bee products and their constituents determined by ESR. Biol Pharm Bull (2009) 1.03
Essential role of neuron-enriched diacylglycerol kinase (DGK), DGKbeta in neurite spine formation, contributing to cognitive function. PLoS One (2010) 1.03
Magnetic resonance imaging findings of Terson's syndrome suggesting a possible vitreous hemorrhage mechanism. Jpn J Ophthalmol (2010) 1.02
Orbital apex syndrome associated with herpes zoster ophthalmicus. Clin Ophthalmol (2011) 1.02
Central retinal artery occlusion resembling Purtscher-like retinopathy. Clin Ophthalmol (2011) 1.02
Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage. Brain Res (2005) 1.01
Role of endoplasmic reticulum stress in light-induced photoreceptor degeneration in mice. J Neurochem (2013) 1.01
Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling. J Neurochem (2008) 1.00
Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells. Brain Res (2008) 1.00
Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA. PLoS One (2010) 1.00
Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity. Eur J Pharmacol (2010) 1.00
Comparative study of cerebral blood flow in patients with normal-tension glaucoma and control subjects. Am J Ophthalmol (2006) 0.99
Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Res (2008) 0.99
Laxative effect of agarwood leaves and its mechanism. Biosci Biotechnol Biochem (2008) 0.99
Protective effects of Chinese propolis and its component, chrysin, against neuronal cell death via inhibition of mitochondrial apoptosis pathway in SH-SY5Y cells. J Agric Food Chem (2008) 0.99
Role of oxidative stress in retinal photoreceptor cell death in N-methyl-N-nitrosourea-treated mice. J Pharmacol Sci (2012) 0.98
Color differences between artificial and natural teeth in removable partial denture wearers. Bull Tokyo Dent Coll (2010) 0.98
Enzymatic resolution and evaluation of enantiomers of cis-5'-hydroxythalidomide. Org Biomol Chem (2008) 0.98
Involvement of P2X7 receptors in the hypoxia-induced death of rat retinal neurons. Invest Ophthalmol Vis Sci (2010) 0.98
Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo. J Pharmacol Exp Ther (2009) 0.97
New quantitative analysis, using high-resolution images, of oxygen-induced retinal neovascularization in mice. Exp Eye Res (2007) 0.96
An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions. Nat Immunol (2010) 0.96
Morphological changes in the visual pathway induced by experimental glaucoma in Japanese monkeys. Exp Eye Res (2009) 0.96
Pancreatobiliary drainage using the EUS-FNA technique: EUS-BD and EUS-PD. J Hepatobiliary Pancreat Surg (2009) 0.96
Regulation of ER molecular chaperone prevents bone loss in a murine model for osteoporosis. J Bone Miner Metab (2009) 0.95
Complete response of anaplastic pancreatic carcinoma to paclitaxel treatment selected by chemosensitivity testing. Int J Clin Oncol (2010) 0.95
A novel calpain inhibitor, ((1S)-1-((((1S)-1-Benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester (SNJ-1945), reduces murine retinal cell death in vitro and in vivo. J Pharmacol Exp Ther (2009) 0.95
Involvement of double-stranded RNA-dependent protein kinase in ER stress-induced retinal neuron damage. Invest Ophthalmol Vis Sci (2007) 0.95
Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers. Acta Ophthalmol (2008) 0.95
Diacylglycerol kinase β knockout mice exhibit lithium-sensitive behavioral abnormalities. PLoS One (2010) 0.94